FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Branch

Research Profile

Chemicals & Drugs

Living Beings

Phenomena

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Divay Chandra; Steven R Duncan; Carl R Fuhrman; Mark T Gladwin; David Gur; Joseph K Leader; Paul M Palevsky; Jessica Bon; Robert A Branch; Jason A Stamm; Joel Weissfeld; Yingze Zhang; Frank C Sciurba
The relationship between pulmonary emphysema and kidney function in smokers.
Nicolas A Stewart; Shama C Buch; Thomas P Conrads; Robert A Branch
A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution.
Brian I Carr; Petr Pancoska; Robert A Branch
HCC in older patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Branch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Divay Chandra; Steven R Duncan; Carl R Fuhrman; Mark T Gladwin; David Gur; Joseph K Leader; Paul M Palevsky; Jessica Bon; Robert A Branch; Jason A Stamm; Joel Weissfeld; Yingze Zhang; Frank C Sciurba
The relationship between pulmonary emphysema and kidney function in smokers.
Chest 2012;142(3):655-62.
2011: Nicolas A Stewart; Shama C Buch; Thomas P Conrads; Robert A Branch
A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution.
The Analyst 2011;136(3):605-12.
2010: Brian I Carr; Petr Pancoska; Robert A Branch
HCC in older patients.
Digestive diseases and sciences 2010;55(12):3584-90.
2010: Brian I Carr; Petr Pancoska; Robert A Branch
Low alpha-fetoprotein hepatocellular carcinoma.
Journal of gastroenterology and hepatology 2010;25(9):1543-9.
2010: Brian I Carr; Petr Pancoska; Robert A Branch
Significance of increased serum GGTP levels in HCC patients.
Hepato-gastroenterology 2010;57(101):869-74.
2010: Brian I Carr; Petr Pancoska; Robert A Branch
HCC in young adults.
Hepato-gastroenterology 2010;57(99-100):436-40.
2010: Petr Pancoska; Brian I Carr; Robert A Branch
Network-based analysis of survival for unresectable hepatocellular carcinoma.
Seminars in oncology 2010;37(2):170-81.
2010: Brian I Carr; Venkateswarlu Kondragunta; Shama C Buch; Robert A Branch
Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.
Cancer 2010;116(5):1305-14.
2009: Alfred A Cecchetti; Bambang Parmanto; Marcella L Vecchio; Sjarif Ahmad; Shama Buch; Nathalie K Zgheib; Stephen J Groark; Anupama Vemuganti; Marjorie Romkes; Frank Sciurba; Michael P Donahoe; Robert A Branch
Team building: electronic management-clinical translational research (eM-CTR) systems.
Clinical and translational science 2009;2(6):449-55.
2009: Jessica M Bon; Joseph K Leader; Joel L Weissfeld; Harvey O Coxson; Bin Zheng; Robert A Branch; Venkateswarlu Kondragunta; Janet S Lee; Yingze Zhang; Augustine M K Choi; Anna Lokshin; Naftali Kaminski; David Gur; Frank C Sciurba
The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease.
PloS one 2009;4(8):e6865.
2008: Brian I Carr; Shama C Buch; Venkateswarlu Kondragunta; Petr Pancoska; Robert A Branch
Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a case cohort study.
Journal of gastroenterology and hepatology 2008;23(8 Pt 1):1259-66.
2008: Shama C Buch; Venkateswarlu Kondragunta; Robert A Branch; Brian I Carr
Gender-based outcomes differences in unresectable hepatocellular carcinoma.
Hepatology international 2008;2(1):95-101.
2008: Josephia R Muindi; Michael D Roth; Robert Wise; John E Connett; George T O'Connor; Joe W Ramsdell; Neil W Schluger; Marjorie Romkes; Robert A Branch; Frank C Sciurba
Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients.
Journal of clinical pharmacology 2008;48(1):96-107.
2007: Nathalie K Zgheib; Reginald F Frye; Timothy S Tracy; Marjorie Romkes; Robert A Branch
Evaluation of flurbiprofen urinary ratios as in vivo indices for CYP2C9 activity.
British journal of clinical pharmacology 2007;63(4):477-87.
2007: Paul Juang; Susan J Skledar; Nathalie K Zgheib; David L Paterson; Emanuel N Vergis; William D Shannon; Nicole T Ansani; Robert A Branch
Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea.
American journal of infection control 2007;35(2):131-7.
2007: Janet S Lee; Matthew R Rosengart; Venkateswarlu Kondragunta; Yingze Zhang; Jessica McMurray; Robert A Branch; Augustine M K Choi; Frank C Sciurba
Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.
Respiratory research 2007;8():64.
2007: Josephia R Muindi; Yibing Peng; John W Wilson; Candace S Johnson; Robert A Branch; Donald L Trump
Monocyte fructose 1,6-bisphosphatase and cytidine deaminase enzyme activities: potential pharmacodynamic measures of calcitriol effects in cancer patients.
Cancer chemotherapy and pharmacology 2007;59(1):97-104.
2006: Nathalie K Zgheib; Reginald F Frye; Timothy S Tracy; Marjorie Romkes; Robert A Branch
Validation of incorporating flurbiprofen into the Pittsburgh cocktail.
Clinical pharmacology and therapeutics 2006;80(3):257-63.
2006: Reginald F Frye; Nathalie K Zgheib; Gary R Matzke; Diego Chaves-Gnecco; Mordecai Rabinovitz; Obaid S Shaikh; Robert A Branch
Liver disease selectively modulates cytochrome P450--mediated metabolism.
Clinical pharmacology and therapeutics 2006;80(3):235-45.
2006: Nicole T Ansani; Carl A Sirio; Thomas Smitherman; Bethany Fedutes-Henderson; Susan J Skledar; Robert J Weber; Nathalie Zgheib; Robert A Branch
Designing a strategy to promote safe, innovative off-label use of medications.
American journal of medical quality : the official journal of the American College of Medical Quality 2006;21(4):255-61.
2006: Nicole T Ansani; Robert A Branch; Bethany Fedutes-Henderson; Thomas Smitherman; Robert J Weber; Susan J Skledar; Nathalie Zgheib; Carl A Sirio
United States medical practice summary: innovative off-label medication use.
American journal of medical quality : the official journal of the American College of Medical Quality 2006;21(4):246-54.
2005: Nicole T Ansani; Bethany Fedutes-Henderson; Susan J Skledar; Robert A Branch; Carl A Sirio; Thomas Smitherman; Robert J Weber
Practical approach to grading evidence for formulary recommendations.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2005;62(14):1498-501.
2005: Shanshan Liu; Reginald F Frye; Robert A Branch; Raman Venkataramanan; John J Fung; Gilbert J Burckart
Effect of age and postoperative time on cytochrome p450 enzyme activity following liver transplantation.
Journal of clinical pharmacology 2005;45(6):666-73.
2005: Brian G Harbrecht; Reginald F Frye; Mazen S Zenati; Robert A Branch; Andrew B Peitzman
Cytochrome P-450 activity is differentially altered in severely injured patients.
Critical care medicine 2005;33(3):541-6.
2004: Zourab Bebia; Shama C Buch; John W Wilson; Reginald F Frye; Marjorie Romkes; Alfred Cecchetti; Diego Chaves-Gnecco; Robert A Branch
Bioequivalence revisited: influence of age and sex on CYP enzymes.
Clinical pharmacology and therapeutics 2004;76(6):618-27.
2003: Joseph A Carcillo; Adedayo Adedoyin; Gilbert J Burckart; Reginald F Frye; Raman Venkataramanan; Carmela Knoll; Kenneth Thummel; Lorin K Roskos; John W Wilson; Susan M Sereika; Marjorie Romkes; Zourab Bebia; Robert A Branch
Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation.
Clinical pharmacology and therapeutics 2003;73(5):456-67.
2002: Lawrence S Engel; Emanuela Taioli; Ruth Pfeiffer; Montserrat Garcia-Closas; Pamela M Marcus; Qing Lan; Paolo Boffetta; Paolo Vineis; Herman Autrup; Douglas A Bell; Robert A Branch; Jürgen Brockmöller; Ann K Daly; Susan R Heckbert; Ivan Kalina; Daehee Kang; Takahiko Katoh; Amalia Lafuente; Henry J Lin; Marjorie Romkes; Jack A Taylor; Nathaniel Rothman
Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review.
American journal of epidemiology 2002;156(2):95-109.
2002: Reginald F Frye; Robert A Branch
Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
British journal of clinical pharmacology 2002;53(2):155-62.
2001: E L Conley; Kim C Coley; Bruce G Pollock; Stacey V DaPos; R Maxwell; Robert A Branch
Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital.
Pharmacotherapy 2001;21(11):1325-30.
2001: Kim C Coley; Margaret M Verrico; Dennis M McNamara; S C Park; M D Cressman; Robert A Branch
Lack of tacrolimus-induced cardiomyopathy.
The Annals of pharmacotherapy 2001;35(9):985-9.
2001: J Matthew Hutzler; Reginald F Frye; Kenneth R Korzekwa; Robert A Branch; S M Huang; Timothy S Tracy
Minimal in vivo activation of CYP2C9-mediated flurbiprofen metabolism by dapsone.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2001;14(1):47-52.
2000: Robert A Branch; Adedayo Adedoyin; Reginald F Frye; John W Wilson; Marjorie Romkes
In vivo modulation of CYP enzymes by quinidine and rifampin.
Clinical pharmacology and therapeutics 2000;68(4):401-11.
2000: Adedayo Adedoyin; Christine E Swenson; Lois E Bolcsak; A Hellmann; D Radowska; G Horwith; AS Janoff; Robert A Branch
A pharmacokinetic study of amphotericin B lipid complex injection (Abelcet) in patients with definite or probable systemic fungal infections.
Antimicrobial agents and chemotherapy 2000;44(10):2900-2.
2000: Kim C Coley; Susan J Skledar; Michael J Fine; D M Yealy; PP Gleason; M L Ryan; Wishwa N Kapoor; Robert A Branch
Changing physician prescribing behavior: the community-acquired pneumonia intervention trial.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2000;57(16):1506-10.
2000: Pamela M Marcus; Richard Hayes; Paolo Vineis; Montserrat Garcia-Closas; Neil E Caporaso; Herman Autrup; Robert A Branch; Jürgen Brockmöller; T Ishizaki; A E Karakaya; J M Ladero; S Mommsen; Henrik Okkels; Marjorie Romkes; I Roots; Nathaniel Rothman
Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(5):461-7.
1999: Kim C Coley; Cameron S Carter; Stacey V DaPos; R Maxwell; J W Wilson; Robert A Branch
Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol.
The Journal of clinical psychiatry 1999;60(12):850-6.
1999: R E Bluhm; Adedayo Adedoyin; D G McCarver; Robert A Branch
Development of dapsone toxicity in patients with inflammatory dermatoses: activity of acetylation and hydroxylation of dapsone as risk factors.
Clinical pharmacology and therapeutics 1999;65(6):598-605.
1999: Raghvendra K Dubey; Y Y Tyurina; Vladimir A Tyurin; Delbert G Gillespie; Robert A Branch; Edwin K Jackson; V E Kagan
Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth.
Circulation research 1999;84(2):229-39.
1998: Joseph A Carcillo; Kenneth R Korzekwa; G S Jones; Robert A Parise; Delbert G Gillespie; Michael J Whalen; P M Kochanek; Robert A Branch; Curtis K Kost
The cytochrome P450 suicide inhibitor, 1-aminobenzotriazole, sensitizes rats to zymosan-induced toxicity.
Research communications in molecular pathology and pharmacology 1998;102(1):57-68.
1998: Adedayo Adedoyin; Reginald F Frye; K Mauro; Robert A Branch
Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail.
British journal of clinical pharmacology 1998;46(3):215-9.
1998: Stevan P Tofovic; Robert A Branch; Edwin K Jackson; M D Cressman; Curtis K Kost
Teaching clinical pharmacology and therapeutics: selective for fourth-year medical students.
Journal of clinical pharmacology 1998;38(8):670-9.
1998: Adedayo Adedoyin; P A Arns; W O Richards; Grant R Wilkinson; Robert A Branch
Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6.
Clinical pharmacology and therapeutics 1998;64(1):8-17.
1998: Gilbert J Burckart; Reginald F Frye; P Kelly; Robert A Branch; A Jain; J J Fung; T E Starzl; Raman Venkataramanan
Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.
Clinical pharmacology and therapeutics 1998;63(3):296-302.
1998: Reginald F Frye; Adedayo Adedoyin; K Mauro; Gary R Matzke; Robert A Branch
Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.
Journal of clinical pharmacology 1998;38(1):82-9.
1998: Adedayo Adedoyin; D D Stiff; David C Smith; Marjorie Romkes; R C Bahnson; R Day; J Hofacker; Robert A Branch; Donald L Trump
All-trans-retinoic acid modulation of drug-metabolizing enzyme activities: investigation with selective metabolic drug probes.
Cancer chemotherapy and pharmacology 1998;41(2):133-9.
1997: P A Arns; Adedayo Adedoyin; A M DiBisceglie; J G Waggoner; J H Hoofnagle; Grant R Wilkinson; Robert A Branch
Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis.
Clinical pharmacology and therapeutics 1997;62(5):527-37.
1997: K Osaka; Yulia Y Tyurina; Raghvendra K Dubey; Vladimir A Tyurin; Vladimir B Ritov; Peter J Quinn; Robert A Branch; Valerian E Kagan
Amphotericin B as an intracellular antioxidant: protection against 2,2'-azobis(2,4-dimethylvaleronitrile)-induced peroxidation of membrane phospholipids in rat aortic smooth muscle cells.
Biochemical pharmacology 1997;54(8):937-45.
1997: Reginald F Frye; Gary R Matzke; Adedayo Adedoyin; J A Porter; Robert A Branch
Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes.
Clinical pharmacology and therapeutics 1997;62(4):365-76.
1997: Adedayo Adedoyin; José F Bernardo; Christine E Swenson; L E Bolsack; G Horwith; S DeWit; E Kelly; J Klasterksy; J P Sculier; D DeValeriola; E Anaissie; G Lopez-Berestein; A Llanos-Cuentas; A Boyle; Robert A Branch
Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.
Antimicrobial agents and chemotherapy 1997;41(10):2201-8.
1997: K Osaka; Vladimir B Ritov; José F Bernardo; Robert A Branch; Valerian E Kagan
Amphotericin B protects cis-parinaric acid against peroxyl radical-induced oxidation: amphotericin B as an antioxidant.
Antimicrobial agents and chemotherapy 1997;41(4):743-7.
1997: Donald L Trump; David C Smith; D Stiff; Adedayo Adedoyin; R Day; Robert R Bahnson; J Hofacker; Robert A Branch
A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis.
Cancer chemotherapy and pharmacology 1997;39(4):349-56.
1996: H D Chern; Michael Becich; Rajendra A Persad; Marjorie Romkes; P Smith; C Collins; Y H Li; Robert A Branch
Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of P53 and retinoblastoma proteins.
The Journal of urology 1996;156(5):1846-9.
1996: S Murakami; T Ohno; José F Bernardo; C A Pfeifer; T Li; Y Zhang; R K Dubey; Robert A Branch; R Sabra
Reduced liver function is the trigger for renal sodium retention following portal vein ligation in the rat.
Journal of gastroenterology and hepatology 1996;11(9):850-6.
1996: Marjorie Romkes; H D Chern; T G Lesnick; Michael Becich; Rajendra A Persad; P Smith; Robert A Branch
Association of low CYP3A activity with p53 mutation and CYP2D6 activity with Rb mutation in human bladder cancer.
Carcinogenesis 1996;17(5):1057-62.
1996: Reginald F Frye; Robert A Branch
Improved high-performance liquid chromatographic determination of debrisoquine and 4-hydroxydebrisoquine in human urine following direct injection.
Journal of chromatography. B, Biomedical applications 1996;677(1):178-82.
1996: Joseph A Carcillo; Robert A Parise; Adedayo Adedoyin; R Frye; Robert A Branch; Marjorie Romkes
CYP2D6 mRNA expression in circulating peripheral blood mononuclear cells correlates with in vivo debrisoquine hydroxylase activity in extensive metabolizers.
Research communications in molecular pathology and pharmacology 1996;91(2):149-159.
1996: Y Irshaid; Robert A Branch; Adedayo Adedoyin
Metabolic interactions of putative cytochrome P4503A substrates with alternative pathways of dapsone metabolism in human liver microsomes.
Drug metabolism and disposition: the biological fate of chemicals 1996;24(2):164-171.
1996: S Murakami; José F Bernardo; Robert A Branch; R Sabra
Adenosine does not mediate renal sodium retention and peripheral vasodilation elicited by partial portal vein ligation in rats.
Hepatology (Baltimore, Md.) 1996;23(2):346-52.
1995: S Murakami; José F Bernardo; T D Jacob; Robert A Branch; R Sabra
Nitric oxide does not contribute to sodium retention and peripheral vasodilation induced by partial portal vein ligation in rats.
Renal physiology and biochemistry 1995;18(4):198-208.
1995: G Wensing; R Sabra; Robert A Branch
Relationship between oxidative hepatic metabolism, urinary sodium excretion and sympathetic nerve activity in experimental cirrhosis in the rat.
Zeitschrift für Gastroenterologie 1995;33(1):1-4.
1995: Robert A Branch; H D Chern; Adedayo Adedoyin; M Romkes-Sparks; T G Lesnick; Rajendra A Persad; Grant R Wilkinson; C M Fleming; A J Dickinson; G N A Sibley
The procarcinogen hypothesis for bladder cancer: activities of individual drug metabolizing enzymes as risk factors.
Pharmacogenetics 1995;5 Spec No():S97-102.
1995: José F Bernardo; S Murakami; Robert A Branch; R Sabra
Potassium depletion potentiates amphotericin-B-induced toxicity to renal tubules.
Nephron 1995;70(2):235-41.
1994: M Romkes-Sparks; A Mnuskin; H D Chern; Rajendra A Persad; C Fleming; G N A Sibley; P Smith; Grant R Wilkinson; Robert A Branch
Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity.
Carcinogenesis 1994;15(9):1955-61.
1994: C M Fleming; Rajendra A Persad; A Kaisary; P Smith; Adedayo Adedoyin; J Porter; Grant R Wilkinson; Robert A Branch
Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer.
Pharmacogenetics 1994;4(4):199-207.
1994: D G May; J Porter; Grant R Wilkinson; Robert A Branch
Frequency distribution of dapsone N-hydroxylase, a putative probe for P4503A4 activity, in a white population.
Clinical pharmacology and therapeutics 1994;55(5):492-500.
1994: Y Irshaid; Adedayo Adedoyin; M Lotze; Robert A Branch
Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
Drug metabolism and disposition: the biological fate of chemicals 1994;22(1):161-4.
1993: T Ohno; Robert A Branch; R Sabra
Sodium retention and hepatic function following partial portal vein ligation in the rat.
Journal of hepatology 1993;18(2):235-43.
1993: D D Stiff; Reginald F Frye; Robert A Branch
Sensitive high-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma.
Journal of chromatography 1993;613(1):127-31.
1993: B C Abels; Robert A Branch; R Sabra
Interaction between thromboxane A2 and angiotensin II in postischemic renal vasoconstriction in dogs.
The Journal of pharmacology and experimental therapeutics 1993;264(3):1285-92.
1993: R E Bluhm; Grant R Wilkinson; R Shelton; Robert A Branch
Genetically determined drug-metabolizing activity and desipramine-associated cardiotoxicity: a case report.
Clinical pharmacology and therapeutics 1993;53(1):89-95.
1992: C Black; G May; M E Csuka; S Lupoli; Grant R Wilkinson; Robert A Branch
Activity of oxidative routes of metabolism of debrisoquin, mephenytoin, and dapsone is unrelated to the pathogenesis of vinyl chloride-induced disease.
Clinical pharmacology and therapeutics 1992;52(6):659-67.
1992: B C Abels; J T Callis; Robert A Branch; R Sabra
Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog.
The Journal of pharmacology and experimental therapeutics 1992;262(1):166-72.
1992: D G May; P A Arns; William O Richards; J Porter; D Ryder; C M Fleming; Grant R Wilkinson; Robert A Branch
The disposition of dapsone in cirrhosis.
Clinical pharmacology and therapeutics 1992;51(6):689-700.
1992: C M Fleming; A Kaisary; Grant R Wilkinson; P Smith; Robert A Branch
The ability to 4-hydroxylate debrisoquine is related to recurrence of bladder cancer.
Pharmacogenetics 1992;2(3):128-34.
1992: R Sabra; Robert A Branch
Effect of amphotericin B on intracellular calcium levels in cultured glomerular mesangial cells.
European journal of pharmacology 1992;226(1):79-85.
1992: C M Fleming; Robert A Branch; Grant R Wilkinson; F Peter Guengerich
Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4.
Molecular pharmacology 1992;41(5):975-80.
1992: Robert A Branch; P E Johnston; J A Koestner; R Bluhm; Charles W Stratton; J R Knight
The formulary: an educational tool for clinical pharmacology.
Clinical pharmacology and therapeutics 1992;51(5):481-8.
1992: R E Bluhm; JA Breyer; R G Bobbitt; L W Welch; A J Wood; Robert A Branch
Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. Part II: Hyperchloraemia and genitourinary symptoms.
Human & experimental toxicology 1992;11(3):211-5.
1992: R E Bluhm; R G Bobbitt; L W Welch; A J Wood; Joseph Bonfiglio; C Sarzen; A J Heath; Robert A Branch
Elemental mercury vapour toxicity, treatment, and prognosis after acute, intensive exposure in chloralkali plant workers. Part I: History, neuropsychological findings and chelator effects.
Human & experimental toxicology 1992;11(3):201-10.
1992: R E Bluhm; W H Rodgers; D L Black; Grant R Wilkinson; Robert A Branch
Cholestasis in transplant patients--what is the role of cyclosporin?
Alimentary pharmacology & therapeutics 1992;6(2):207-19.
1992: R E Bluhm; L Welch; Robert A Branch
Increased blood and urine copper after residential exposure to copper naphthenate.
Journal of toxicology. Clinical toxicology 1992;30(1):99-108.
1992: P Li; J Benitez; Dan Mark Roden; Robert A Branch
Angiotensin II facilitates tricyclic antidepressant-induced changes in QRS-duration in the rat.
Journal of toxicology. Clinical toxicology 1992;30(1):83-98.
1992: Rajendra A Persad; C M Fleming; Grant R Wilkinson; P J Smith; Robert A Branch
Bladder cancer recurrence and its association with cytochrome P-450IID6 activity.
Progress in clinical and biological research 1992;378():19-27.
1991: R Sabra; Robert A Branch
Mechanisms of amphotericin B-induced decrease in glomerular filtration rate in rats.
Antimicrobial agents and chemotherapy 1991;35(12):2509-14.
1991: Nancy Brown; D Ryder; Robert A Branch
A pharmacodynamic interaction between caffeine and phenylpropanolamine.
Clinical pharmacology and therapeutics 1991;50(4):363-71.
1991: T Ohno; R Sabra; Robert A Branch
Sodium retention and hepatic function after two-thirds hepatectomy in the rat.
Hepatology (Baltimore, Md.) 1991;14(3):511-7.
1991: A Llanos; J Cieza; José F Bernardo; J Echevarria; I Biaggioni; R Sabra; Robert A Branch
Effect of salt supplementation on amphotericin B nephrotoxicity.
Kidney international 1991;40(2):302-8.
1991: Nancy Brown; J Porter; D Ryder; Robert A Branch
Caffeine potentiates the renin response to diazoxide in man. Evidence for a regulatory role of endogenous adenosine.
The Journal of pharmacology and experimental therapeutics 1991;256(1):56-61.
1990: D G May; J A Porter; J P Uetrecht; Grant R Wilkinson; Robert A Branch
The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects.
Clinical pharmacology and therapeutics 1990;48(6):619-27.
1990: R Bluhm; Robert A Branch; P Johnston; R Stein
Aplastic anemia associated with canthaxanthin ingested for 'tanning' purposes.
JAMA : the journal of the American Medical Association 1990;264(9):1141-2.
1990: D G May; C M Black; N J Olsen; M E Csuka; S B Tanner; L Bellino; J A Porter; Grant R Wilkinson; Robert A Branch
Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoin.
Clinical pharmacology and therapeutics 1990;48(3):286-95.
1990: G Wensing; R Sabra; Robert A Branch
Renal and systemic hemodynamics in experimental cirrhosis in rats: relation to hepatic function.
Hepatology (Baltimore, Md.) 1990;12(1):13-9.
1990: R Sabra; Robert A Branch
Role of sodium in protection by extended-spectrum penicillins against tobramycin-induced nephrotoxicity.
Antimicrobial agents and chemotherapy 1990;34(6):1020-5.
1990: P E Johnston; JD Morrow; Robert A Branch
Use of a database computer program to identify trends in reporting of adverse drug reactions.
American journal of hospital pharmacy 1990;47(6):1321-7.
1990: G Wensing; R Sabra; Robert A Branch
The onset of sodium retention in experimental cirrhosis in rats is related to a critical threshold of liver function.
Hepatology (Baltimore, Md.) 1990;11(5):779-86.
1990: G Wensing; Robert A Branch
Phenobarbital influences the development of sodium retention in liver disease induced by bile duct ligation in the rat.
Hepatology (Baltimore, Md.) 1990;11(5):773-8.
1990: R Sabra; K Takahashi; Robert A Branch; KAMAL BADR
Mechanisms of amphotericin B-induced reduction of the glomerular filtration rate: a micropuncture study.
The Journal of pharmacology and experimental therapeutics 1990;253(1):34-7.
1990: C J Kuan; Robert A Branch; E K Jackson
Effect of an adenosine receptor antagonist on acute amphotericin B nephrotoxicity.
European journal of pharmacology 1990;178(3):285-91.
1990: R Sabra; Robert A Branch
Amphotericin B nephrotoxicity.
Drug safety : an international journal of medical toxicology and drug experience 1990;5(2):94-108.
1990: G Deray; R Sabra; W A Herzer; E K Jackson; Robert A Branch
Interaction between angiotensin II and adenosine in mediating the vasoconstrictor response to intrarenal hypertonic saline infusions in the dog.
The Journal of pharmacology and experimental therapeutics 1990;252(2):631-5.
1989: S Paul; E K Jackson; David Robertson; Robert A Branch; Italo Biaggioni
Caffeine potentiates the renin response to furosemide in rats. Evidence for a regulatory role of endogenous adenosine.
The Journal of pharmacology and experimental therapeutics 1989;251(1):183-7.
1989: A Ohnishi; T Ohnishi; W Stevenhead; R D Robinson; A Glick; Denis M O'Day; R Sabra; E K Jackson; Robert A Branch
Sodium status influences chronic amphotericin B nephrotoxicity in rats.
Antimicrobial agents and chemotherapy 1989;33(8):1222-7.
1989: A Ohnishi; T D Bryant; K R Branch; R Sabra; Robert A Branch
Role of sodium in the protective effect of ticarcillin on gentamicin nephrotoxicity in rats.
Antimicrobial agents and chemotherapy 1989;33(6):928-32.
1989: G Deray; Robert A Branch; E K Jackson
Methylxanthines augment the renin response to suprarenal-aortic constriction.
Naunyn-Schmiedeberg's archives of pharmacology 1989;339(6):690-6.
1989: G Deray; Robert A Branch; A Ohnishi; E K Jackson
Adenosine inhibits renin release induced by suprarenal-aortic constriction and prostacyclin.
Naunyn-Schmiedeberg's archives of pharmacology 1989;339(5):590-5.
1989: J T Callis; C J Kuan; K R Branch; B C Abels; R Sabra; E K Jackson; Robert A Branch
Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
The Journal of pharmacology and experimental therapeutics 1989;248(3):1123-9.
1989: S A Ward; Thomas Walle; U K Walle; Grant R Wilkinson; Robert A Branch
Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities.
Clinical pharmacology and therapeutics 1989;45(1):72-9.
1989: Grant R Wilkinson; F Peter Guengerich; Robert A Branch
Genetic polymorphism of S-mephenytoin hydroxylation.
Pharmacology & therapeutics 1989;43(1):53-76.
1988: G R McNeal; W H Maynard; Robert A Branch; T A Powers; P A Arns; K Gunter; J Michael Fitzpatrick; C L Partain
Liver volume measurements and three-dimensional display from MR images.
Radiology 1988;169(3):851-4.
1988: Kenneth R Hande; R Bennett; R Hamilton; T Grote; Robert A Branch
Metabolism and excretion of etoposide in isolated, perfused rat liver models.
Cancer research 1988;48(20):5692-5.
1988: John A Oates; garret fitzgerald; Robert A Branch; E K Jackson; H R Knapp; L Jackson Roberts
Clinical implications of prostaglandin and thromboxane A2 formation (2).
The New England journal of medicine 1988;319(12):761-7.
1988: John A Oates; garret fitzgerald; Robert A Branch; E K Jackson; H R Knapp; L Jackson Roberts
Clinical implications of prostaglandin and thromboxane A2 formation (1).
The New England journal of medicine 1988;319(11):689-98.
1988: A Ohnishi; P Li; Robert A Branch; Italo Biaggioni; E K Jackson
Adenosine in renin-dependent renovascular hypertension.
Hypertension 1988;12(2):152-61.
1988: D R Jones; S D Hall; E K Jackson; Robert A Branch; Grant R Wilkinson
Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein binding.
The Journal of pharmacology and experimental therapeutics 1988;245(3):816-22.
1988: Kenneth R Hande; L Anthony; R Hamilton; R Bennett; B Sweetman; Robert A Branch
Identification of etoposide glucuronide as a major metabolite of etoposide in the rat and rabbit.
Cancer research 1988;48(7):1829-34.
1988: Robert A Branch; P Johnston
Therapeutic advisory program: an opportunity for clinical pharmacology.
Clinical pharmacology and therapeutics 1988;43(3):223-7.
1988: E K Jackson; F Goto; H D Uderman; R J Workman; W A Herzer; garret fitzgerald; Robert A Branch
Effects of thromboxane synthase inhibitors on renal function.
Naunyn-Schmiedeberg's archives of pharmacology 1988;337(2):183-90.
1987: F Goto; E K Jackson; A Ohnishi; W Herzer; Robert A Branch
Effect of cyclooxygenase and thromboxane synthase inhibition on the response to angiotensin II in the hypoperfused canine kidney.
The Journal of pharmacology and experimental therapeutics 1987;243(3):799-803.
1987: D G May; Charles W Stratton; W D Denney; F L Watts; gordon bernard; Robert A Branch
Vancomycin entry into lung lymph in sheep.
Antimicrobial agents and chemotherapy 1987;31(11):1689-91.
1987: A Kaisary; P Smith; E Jaczq; C B McAllister; Grant R Wilkinson; Wayne A Ray; Robert A Branch
Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors.
Cancer research 1987;47(20):5488-93.
1987: H T Heidemann; E K Jackson; J F Gerkens; Robert A Branch
Intrarenal hypertonic saline infusions in dogs with thoracic caval constriction.
Kidney international 1987;32(4):488-92.
1987: P J Wedlund; B J Sweetman; Grant R Wilkinson; Robert A Branch
Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in man.
Drug metabolism and disposition: the biological fate of chemicals 1987;15(2):277-9.
1987: Robert A Branch; F Goto; A Ohnishi; W Herzer; E K Jackson
Renal thromboxane A2 release stimulated by angiotensin II in the hypoperfused canine kidney.
Advances in prostaglandin, thromboxane, and leukotriene research 1987;17B():749-52.
1986: M L Watson; R J Workman; W Herzer; Robert A Branch; J A Oates; A R Brash
Systemic synthesis of prostaglandin I2 following sustained infusion of angiotensin II in conscious dogs.
European journal of pharmacology 1986;127(1-2):9-16.
1985: K Nakamura; F Goto; Wayne A Ray; C B McAllister; E Jacqz; Grant R Wilkinson; Robert A Branch
Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations.
Clinical pharmacology and therapeutics 1985;38(4):402-8.
1985: P J Wedlund; W S Aslanian; E Jacqz; C B McAllister; Robert A Branch; Grant R Wilkinson
Phenotypic differences in mephenytoin pharmacokinetics in normal subjects.
The Journal of pharmacology and experimental therapeutics 1985;234(3):662-9.
1985: H T Heidemann; J F Gerkens; E K Jackson; Robert A Branch
Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide.
Naunyn-Schmiedeberg's archives of pharmacology 1985;329(2):201-5.
1985: H T Heidemann; E K Jackson; J F Gerkens; R J Workman; Robert A Branch
Unilaterally nephrectomized rat with aortic ligation: a uremic model of severe hypertension.
Clinical and experimental hypertension. Part A, Theory and practice 1985;7(8):1109-20.
1984: P J Wedlund; W S Aslanian; C B McAllister; Grant R Wilkinson; Robert A Branch
Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphism.
Clinical pharmacology and therapeutics 1984;36(6):773-80.
1984: E K Jackson; H D Uderman; W A Herzer; Robert A Branch
Attenuation of noradrenergic neurotransmission by the thromboxane synthetase inhibitor, UK 38,485.
Life sciences 1984;35(2):221-8.
1984: P J Wedlund; B J Sweetman; C B McAllister; Robert A Branch; Grant R Wilkinson
Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography.
Journal of chromatography 1984;307(1):121-7.
1983: H T Heidemann; J F Gerkens; E K Jackson; Robert A Branch
Effect of aminophylline on renal vasoconstriction produced by amphotericin B in the rat.
Naunyn-Schmiedeberg's archives of pharmacology 1983;324(2):148-52.
1983: E K Jackson; J F Gerkens; J B Zimmerman; H D Uderman; J A Oates; R J Workman; Robert A Branch
Prostaglandin biosynthesis does not participate in hypercapnia-induced cerebral vasodilatation in the dog.
The Journal of pharmacology and experimental therapeutics 1983;226(2):486-92.
1983: J F Gerkens; H T Heidemann; E K Jackson; Robert A Branch
Aminophylline inhibits renal vasoconstriction produced by intrarenal hypertonic saline.
The Journal of pharmacology and experimental therapeutics 1983;225(3):611-5.
1983: J F Gerkens; H T Heidemann; E K Jackson; Robert A Branch
Effect of aminophylline on amphotericin B nephrotoxicity in the dog.
The Journal of pharmacology and experimental therapeutics 1983;224(3):609-13.
1982: E K Jackson; W A Herzer; J B Zimmerman; J A Oates; Robert A Branch; J F Gerkens
Effects of indomethacin on beta adrenoreceptor-stimulated renin release in the dog.
The Journal of pharmacology and experimental therapeutics 1982;222(2):414-8.
1982: E K Jackson; H T Heidemann; Robert A Branch; J F Gerkens
Low dose intrarenal infusions of PGE2, PGI2, and 6-keto-PGE1 vasodilate the in vivo rat kidney.
Circulation research 1982;51(1):67-72.
1981: E K Jackson; W A Herzer; J B Zimmerman; Robert A Branch; J A Oates; J F Gerkens
6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
The Journal of pharmacology and experimental therapeutics 1981;216(1):24-7.